These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17663410

  • 1. Graft vs. host disease after liver transplantation: a new approach is needed.
    Perri R, Assi M, Talwalkar J, Heimbach J, Hogan W, Moore SB, Rosen CB.
    Liver Transpl; 2007 Aug; 13(8):1092-9. PubMed ID: 17663410
    [Abstract] [Full Text] [Related]

  • 2. Graft-versus-host disease after liver transplantation: successful treatment of a case.
    Lu Y, Wu LQ, Zhang BY, Cao JY.
    Transplant Proc; 2008 Dec; 40(10):3784-6. PubMed ID: 19100490
    [Abstract] [Full Text] [Related]

  • 3. [Graft versus host disease after liver transplantation: a report of 3 cases].
    Liang TB, Tang XF, Zheng SS, Lu AW, Wang WL, Shen Y, Zhang M, Meng XQ.
    Zhonghua Yi Xue Za Zhi; 2004 May 17; 84(10):826-9. PubMed ID: 15200885
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for severe hepatic graft-versus-host disease: an analysis of aggregate survival data.
    Barshes NR, Myers GD, Lee D, Karpen SJ, Lee TC, Patel AJ, Finegold M, Goss JA.
    Liver Transpl; 2005 May 17; 11(5):525-31. PubMed ID: 15838886
    [Abstract] [Full Text] [Related]

  • 5. Graft versus host disease after liver transplantation - a single center experience and review of literature.
    Kohler S, Pascher A, Junge G, Sauer IM, Nagy M, Schönemann C, Koch M, Neumann U, Pratschke J, Neuhaus P.
    Transpl Int; 2008 May 17; 21(5):441-51. PubMed ID: 18266778
    [Abstract] [Full Text] [Related]

  • 6. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
    Thin L, Macquillan G, Adams L, Garas G, Seow C, Cannell P, Augustson B, Mitchell A, Delriveire L, Jeffrey G.
    Liver Transpl; 2009 Apr 17; 15(4):421-6. PubMed ID: 19326415
    [Abstract] [Full Text] [Related]

  • 7. Diagnosis and treatment for graft-versus-host disease after liver transplantation: two case reports.
    Wang B, Lu Y, Yu L, Liu C, Wu Z, Liu X.
    Transplant Proc; 2007 Jun 17; 39(5):1696-8. PubMed ID: 17580224
    [Abstract] [Full Text] [Related]

  • 8. Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management.
    Chinnakotla S, Smith DM, Domiati-Saad R, Agura ED, Watkins DL, Netto G, Uemura T, Sanchez EQ, Levy MF, Klintmalm GB.
    Liver Transpl; 2007 Jan 17; 13(1):157-61. PubMed ID: 17192857
    [Abstract] [Full Text] [Related]

  • 9. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
    Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, Di Martino V.
    Liver Transpl; 2009 Jul 17; 15(7):682-5. PubMed ID: 19562700
    [Abstract] [Full Text] [Related]

  • 10. Chronic graft-versus-host disease after liver transplantation: a case report.
    Yilmaz M, Ozdemir F, Akbulut S, Ersan V, Koc C, Koc S, Yilmaz S.
    Transplant Proc; 2012 Jul 17; 44(6):1751-3. PubMed ID: 22841262
    [Abstract] [Full Text] [Related]

  • 11. Late onset of severe graft-versus-host disease following liver transplantation.
    Sun B, Zhao C, Xia Y, Li G, Cheng F, Li J, Zhang F, Wang X.
    Transpl Immunol; 2006 Nov 17; 16(3-4):250-3. PubMed ID: 17138062
    [Abstract] [Full Text] [Related]

  • 12. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
    Creamer D, Martyn-Simmons CL, Osborne G, Kenyon M, Salisbury JR, Devereux S, Pagliuca A, Ho AY, Mufti GJ, du Vivier AW.
    Arch Dermatol; 2007 Sep 17; 143(9):1157-62. PubMed ID: 17875877
    [Abstract] [Full Text] [Related]

  • 13. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy.
    Hoffner MV, Carrizosa Esquivel A, Pulpillo Ruiz A, Herrera Saval A, Conejo-Mir J, Camacho FM.
    J Drugs Dermatol; 2009 Nov 17; 8(11):1027-9. PubMed ID: 19894371
    [Abstract] [Full Text] [Related]

  • 14. Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia.
    Schäppi MG, Belli DC, Rimensberger PC, Chardot C, Kaya G, Tiercy JM, Ozsahin H.
    Liver Transpl; 2006 Nov 17; 12(11):1693-7. PubMed ID: 17058230
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
    Murashige N, Kami M, Mori S, Katayama Y, Kobayashi K, Onishi Y, Hori A, Kishi Y, Hamaki T, Tajima K, Kanda Y, Tanosaki R, Takaue Y.
    Am J Hematol; 2008 Aug 17; 83(8):630-4. PubMed ID: 18454459
    [Abstract] [Full Text] [Related]

  • 20. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M, Sun Z, Sun QY, Han Q, Yu CL, Wang DH, Qiao JH, Chen B, Sun WJ, Hu KX, Liu GX, Liu B, Zhao RC, Ai H.
    Biol Blood Marrow Transplant; 2009 Aug 17; 15(8):930-7. PubMed ID: 19589482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.